Literature DB >> 23850459

Mutations in HIV-1 reverse transcriptase cause misfolding and miscleavage by the viral protease.

Linda L Dunn1, Paul L Boyer, Patrick K Clark, Stephen H Hughes.   

Abstract

Previous work on mutations in the thumb of HIV-1 reverse transcriptase (RT) showed that the majority of the mutant RTs were degraded (by the viral protease) to various extents in virions. This degradation was, in most cases, temperature sensitive, and presumably was due to a partial unfolding of the protein at 37°C. We used recombinant proteins to investigate the effects of the mutations on the thermal stability and proteolytic degradation of RT. Both subunits contribute to the stability of RT. In general, the differences in stability between the mutants and WT were greater if the mutation was in p51 rather than p66. Expressing the Pol polyprotein containing the RT mutants in Escherichia coli produced results similar to what was seen in virions; the mutant RTs were misfolded and/or degraded at 37°C, but were better folded and processed at 30°C. Published by Elsevier Inc.

Entities:  

Keywords:  Differential scanning fluorescence; HIV-1; Protease; Reverse transcriptase; Stability

Mesh:

Substances:

Year:  2013        PMID: 23850459      PMCID: PMC3804327          DOI: 10.1016/j.virol.2013.06.017

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  19 in total

1.  Immunologic and proteolytic analysis of HIV-1 reverse transcriptase structure.

Authors:  A L Ferris; A Hizi; S D Showalter; S Pichuantes; L Babe; C S Craik; S H Hughes
Journal:  Virology       Date:  1990-04       Impact factor: 3.616

2.  Dimerization of human immunodeficiency virus type 1 reverse transcriptase. A target for chemotherapeutic intervention.

Authors:  T Restle; B Müller; R S Goody
Journal:  J Biol Chem       Date:  1990-06-05       Impact factor: 5.157

3.  A genetic approach for identifying critical residues in the fingers and palm subdomains of HIV-1 reverse transcriptase.

Authors:  J A Wrobel; S F Chao; M J Conrad; J D Merker; R Swanstrom; G J Pielak; C A Hutchison
Journal:  Proc Natl Acad Sci U S A       Date:  1998-01-20       Impact factor: 11.205

4.  Expression of soluble, enzymatically active, human immunodeficiency virus reverse transcriptase in Escherichia coli and analysis of mutants.

Authors:  A Hizi; C McGill; S H Hughes
Journal:  Proc Natl Acad Sci U S A       Date:  1988-02       Impact factor: 11.205

5.  Mutations that abrogate human immunodeficiency virus type 1 reverse transcriptase dimerization affect maturation of the reverse transcriptase heterodimer.

Authors:  Johanna Wapling; Katie L Moore; Secondo Sonza; Johnson Mak; Gilda Tachedjian
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

6.  Construction and characterization of a temperature-sensitive human immunodeficiency virus type 1 reverse transcriptase mutant.

Authors:  M Huang; R Zensen; M Cho; M A Martin
Journal:  J Virol       Date:  1998-03       Impact factor: 5.103

7.  The ribonuclease H activity of the reverse transcriptases of human immunodeficiency viruses type 1 and type 2 is affected by the thumb subdomain of the small protein subunits.

Authors:  Z Sevilya; S Loya; S H Hughes; A Hizi
Journal:  J Mol Biol       Date:  2001-08-31       Impact factor: 5.469

8.  The effects of cysteine mutations on the reverse transcriptases of human immunodeficiency virus types 1 and 2.

Authors:  A Hizi; M Shaharabany; R Tal; S H Hughes
Journal:  J Biol Chem       Date:  1992-01-15       Impact factor: 5.157

9.  Amino acid substitutions at position 190 of human immunodeficiency virus type 1 reverse transcriptase increase susceptibility to delavirdine and impair virus replication.

Authors:  Wei Huang; Andrea Gamarnik; Kay Limoli; Christos J Petropoulos; Jeannette M Whitcomb
Journal:  J Virol       Date:  2003-01       Impact factor: 5.103

10.  Subunit specificity of mutations that confer resistance to nonnucleoside inhibitors in human immunodeficiency virus type 1 reverse transcriptase.

Authors:  P L Boyer; J Ding; E Arnold; S H Hughes
Journal:  Antimicrob Agents Chemother       Date:  1994-09       Impact factor: 5.191

View more
  5 in total

1.  Structural integrity of the ribonuclease H domain in HIV-1 reverse transcriptase.

Authors:  Ryan L Slack; Justin Spiriti; Jinwoo Ahn; Michael A Parniak; Daniel M Zuckerman; Rieko Ishima
Journal:  Proteins       Date:  2015-07-01

Review 2.  HIV Genome-Wide Protein Associations: a Review of 30 Years of Research.

Authors:  Guangdi Li; Erik De Clercq
Journal:  Microbiol Mol Biol Rev       Date:  2016-06-29       Impact factor: 11.056

Review 3.  Reverse Transcription of Retroviruses and LTR Retrotransposons.

Authors:  Stephen H Hughes
Journal:  Microbiol Spectr       Date:  2015-04

4.  ERVK polyprotein processing and reverse transcriptase expression in human cell line models of neurological disease.

Authors:  Mamneet Manghera; Jennifer Ferguson; Renée Douville
Journal:  Viruses       Date:  2015-01-20       Impact factor: 5.048

5.  Two Coselected Distal Mutations in HIV-1 Reverse Transcriptase (RT) Alter Susceptibility to Nonnucleoside RT Inhibitors and Nucleoside Analogs.

Authors:  Paul L Boyer; Kevin Melody; Steven J Smith; Linda L Dunn; Chris Kline; Douglas K Fischer; Richa Dwivedi; Pat Clark; Stephen H Hughes; Zandrea Ambrose
Journal:  J Virol       Date:  2019-05-15       Impact factor: 5.103

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.